Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).
Notes:
Priority ratings from 23 EU countries plus Bulgaria and Norway. Countries not supplying these ratings were Ireland, Cyprus, Lithuania and the Netherlands.
Ratings on the 'extent of use' were provided by experts from all 25 EU countries plus Bulgaria and Norway. The French and Flemish Communities in Belgium provided separate ratings, bringing the total number of replies to 28.
See also 'General notes for interpreting data' on the Explanatory notes and help page.
Sources:
National Focal Points expert survey, Structured Questionnaire SQ 23 (2004) Question 5.